Industry veteran appointed as Chief Scientific Officer of OxStem Ltd
Dr. Georg C. Terstappen has been appointed to the role of Chief Scientific Officer (CSO) of spinout OxStem Ltd.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Dr. Georg C. Terstappen has been appointed to the role of Chief Scientific Officer (CSO) of spinout OxStem Ltd.
The Oxford University spinout will use the investment to further develop its exosome technology, capable of delivering drugs to previously inaccessible parts of the body.
Celleron Therapeutics, spun out of the University in 2005, has commenced a Phase Ib/II clinical trial investigating drug combination therapy for colorectal cancer.
Oxford University spinout external investment nears £1.9bn since 2011 - £506m of which was in the past twelve months.
Opsydia, an Oxford University spinout founded last year to create a new level of diamond and gemstone security, officially launches with De Beers deal.
Oxford Sciences Innovation leads round into Orbit Discovery, an Oxford University spinout developing a peptide platform.
Oxford University spinout Cytox has announced an extension of its test for assessing the genetic risk of developing Alzheimer's disease.
Preserving livers at body temperature has been shown to improve transplant success and to increase the number of viable donor livers available for transplant. The study, which used a normothermic perfusion device from spinout OrganOx, presages shorter waiting lists for patients and lower mortality rates.
Momentum behind the Oxford innovation ecosystem keeps building, with a third of spinouts formed over OUI's 30 year history created in the past three years.
Brainomix builds on partnership with Boehringer Ingelheim for AI-assisted fast treatment of stroke victims in latest venture round.